"The government suggests that weight-loss drugs could boost the economy by helping obese individuals return to work, highlighting a potential economic angle to health interventions."
"NHS experts express concerns over the existing treatment services being overstretched, noting unprecedented demand from patients seeking weight-loss drugs, complicating accessibility for those in need."
"Wegovy, a drug already available through the NHS, requires prescription through specialist weight management services, with limited access contingent on specific health conditions."
"Clinical trials indicate that patients using Wegovy could lose more than 10% of their body weight within a year, especially when coupled with lifestyle changes, though weight regain post-treatment is a risk."
Collection
[
|
...
]